TP53TG1/STAT axis is involved in the development of colon cancer through affecting PD-L1 expression and immune escape mechanism of tumor cells

被引:0
|
作者
Ji, Wenmin [1 ,3 ]
Wang, Wenyan [2 ]
Wei, Yanfang [1 ]
机构
[1] Shanxi Med Univ, Hosp 1, Taiyuan 030001, Shanxi, Peoples R China
[2] Shanxi Inst Food & Drug Control, Taiyuan 030001, Shanxi, Peoples R China
[3] Shanxi Med Univ, Hosp 1, 85 Jiefang South Rd, Taiyuan 030000, Shanxi, Peoples R China
来源
AMERICAN JOURNAL OF CANCER RESEARCH | 2023年 / 13卷 / 11期
关键词
PD-1/PD-L1; TP53TG1; immune escape; STAT pathway; colon cancer; REGULATORY T-CELLS; LONG NONCODING RNA; CD8(+) T; IMMUNOTHERAPY; COMBINATION; THERAPY; TARGET; RESISTANCE; PROGNOSIS; CD4(+);
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This research is dedicated to investigating the mechanism of programmed cell death ligand 1 (PD-L1) and tumor protein 53 target gene 1 (TP53TG1) in immune regulation of colon cancer (CC). Expressions of TP53TG1, PDL1 and signal transducers and activators of transcription (STATs) in CC and their correlation were detected through bioinformatics analysis. Effects of PD-L1 and TP53TG1 on the CC were assessed by in vivo and in vitro experiments. Herein, PD-L1 level was negatively correlated with TP53TG1 expression, but was positively correlated with the levels of STATs. Both overexpressed TP53TG1 and PD-L1 antibody reversed the effects of CT26 cells on inhibiting cell proliferation, cytokine secretion and PD-L1 level, and enhancing the cytotoxicity of NK cells and CD8+ T cells. TP53TG1 reduced PD-L1 level by inactivating STATs pathway. Downregulation of PD-L1 increased cytokine secretion and T lymphocyte killing ability, promoted tumor cell apoptosis, and inhibited the tumor growth. Altogether, TP53TG1/STAT axis regulates the immunomodulatory mechanism of CC by reducing PD-L1 expression.
引用
收藏
页码:5218 / +
页数:19
相关论文
共 50 条
  • [41] The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines
    Doi, Toshifumi
    Ishikawa, Takeshi
    Okayama, Tetsuya
    Oka, Kaname
    Mizushima, Katsura
    Yasuda, Tomoyo
    Sakamoto, Naoyuki
    Katada, Kazuhiro
    Kamada, Kazuhiro
    Uchiyama, Kazuhiko
    Handa, Osamu
    Takagi, Tomohisa
    Naito, Yuji
    Itoh, Yoshito
    ONCOLOGY REPORTS, 2017, 37 (03) : 1545 - 1554
  • [42] MYC Inhibition and TP53 Activation Synergistically Suppress Immune Checkpoint Ligand PD-L1 Expression in AML Cells
    Bland, Joshua B.
    Tse, William T.
    BLOOD, 2016, 128 (22)
  • [43] IL-27 EXPRESSED IN THE TUMOR MICROENVIRONMENT IS CORRELATED WITH PD-L1 LEVELS AND CAN INDUCE PD-L1 EXPRESSION ON IMMUNE AND TUMOR CELLS
    Golan, Karin
    Masia, Ricard
    Yang, Yu
    Ren, Yue
    White, Kerry
    Lee, Benjamin
    Palombella, Vito
    Hill, Jonathan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1124 - A1124
  • [44] SPIB Knockdown Inhibits the Immune Escape of Ovarian Cancer Cells by Reducing PD-L1 (CD274) Expression and Inactivating the JAK/STAT Pathway
    Gu, Wenfei
    Qi, Guangtao
    Chen, Li
    IRANIAN JOURNAL OF IMMUNOLOGY, 2023, 20 (03) : 335 - 347
  • [45] BRD4 promotes immune escape of glioma cells by upregulating PD-L1 expression
    Liu, Yongsheng
    Cai, Lize
    Wang, Hao
    Yao, Lin
    Wu, Yue
    Zhang, Kai
    Su, Zuopeng
    Zhou, Youxin
    JOURNAL OF NEURO-ONCOLOGY, 2025, 171 (03) : 669 - 679
  • [46] USP7 Enables Immune Escape of Glioma Cells by Regulating PD-L1 Expression
    Li, Bing
    Wang, Bin
    IMMUNOLOGICAL INVESTIGATIONS, 2022, 51 (07) : 1921 - 1937
  • [47] PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
    Hye Ryun Kim
    Sang-Jun Ha
    Min Hee Hong
    Su Jin Heo
    Yoon Woo Koh
    Eun Chang Choi
    Eun Kyung Kim
    Kyoung Ho Pyo
    Inkyung Jung
    Daekwan Seo
    Jaewoo Choi
    Byoung Chul Cho
    Sun Och Yoon
    Scientific Reports, 6
  • [48] PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
    Kim, Hye Ryun
    Ha, Sang-Jun
    Hong, Min Hee
    Heo, Su Jin
    Koh, Yoon Woo
    Choi, Eun Chang
    Kim, Eun Kyung
    Pyo, Kyoung Ho
    Jung, Inkyung
    Seo, Daekwan
    Choi, Jaewoo
    Cho, Byoung Chul
    Yoon, Sun Och
    SCIENTIFIC REPORTS, 2016, 6
  • [49] PD-1/PD-L1 expression in colorectal cancer and its implications for apoptosis and tumor immune evasion
    Gasser, Martin
    Grimm, Martin
    Nichiporuk, Ekaterina
    Bueter, Marco
    Lutz, Jens
    Lebedeva, Tatiana
    Koenigshausen, Matthias
    Thalheimer, Andreas
    Thiede, Arnulf
    Heemann, Uwe
    Meyer, Detlef
    Waaga-Gasser, Ana Maria
    CANCER RESEARCH, 2006, 66 (08)
  • [50] Tumor-derived extracellular vesicles containing microRNA-1290 promote immune escape of cancer cells through the Grhl2/ZEB1/PD-L1 axis in gastric cancer
    Liang, Yuan
    Liu, Yang
    Zhang, Qingfu
    Zhang, Heng
    Du, Jiang
    TRANSLATIONAL RESEARCH, 2021, 231 : 102 - 112